MRI study of blood-vessel and tissue signs in child liver disease
Part of Digestive system, Immune system & allergy clinical trials.
This trial uses MRI scans to look for “biomarkers,” which are measurable signs in the liver, to better understand autoimmune liver diseases in children and teens. It may help doctors track disease and improve care by finding imaging patterns linked to illness.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 6 and 23 years old
- Have a diagnosis (or strong suspicion) of autoimmune liver disease such as AIH or PSC
- You have not had a liver transplant in the past
- You are not pregnant and can follow pregnancy rules during the study
- You can safely have an MRI (no incompatible metal/pacemaker, and not severely claustrophobic)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses MRI scans to find “biomarkers,” or imaging clues, that may help predict how autoimmune liver conditions will progress in children and young adults. If you qualify, you may get MRI imaging to see whether it relates to future health outcomes.
This study tests whether yearly MRI scans of the liver (called Multiscan and MRCP+) can help monitor primary sclerosing cholangitis (a liver disease) and detect problems early. If you join, you'd get these special scans to track your liver health over time.
This study uses advanced MRI scans to get a clearer picture of liver fat, inflammation, and scarring in people with chronic liver disease. It aims to help doctors diagnose and understand liver problems better.
This study uses a new MRI technique to look at blood flow and iron in the liver, without needing a biopsy. It tests how well this newer imaging method works in people with liver disease and in healthy volunteers, to help improve diagnosis and monitoring.
This study uses a special PET/MRI scanner to take detailed pictures of your liver and bile ducts. It may help doctors better understand and manage PSC without any treatment or medication.
This study looks at MRI images taken as part of routine care to see if they can help predict future health problems in people with liver disease. If you already have an MRI scheduled for clinical reasons, this may help doctors better estimate risk over time.
Hear when a new Autoimmune Liver Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.